Biodiversity Science ›› 2016, Vol. 24 ›› Issue (1): 114-120.doi: 10.17520/biods.2015151

• Orginal Article • Previous Article     Next Article

International negotiations on synthetic biology and China’s implementation strategies within the Convention on Biological Diversity framework

Minghao Qiu1, Yue Huang1, Jieqing Zhang2, Yi Huang1, *()   

  1. 1 College of Environmental Sciences and Engineering, Peking University, Beijing 100871
    2 Department of International Cooperation, Ministry of Environmental Protection of China, Beijing 100035
  • Received:2015-06-03 Accepted:2015-09-15 Online:2016-06-12
  • Huang Yi

Much attention has been paid to synthetic biology in recent years for its potential applications and unpredictable eco-risks. The 12th Conference of the Parties (COP12) of Convention on Biological Diversity (CBD), held in Korea in October 2014, formally addressed the topic of synthetic biology for the first time. Based on literature retrieved from CBD documents and technical reports, this paper reviews the process by which synthetic biology entered the agenda of CBD negotiations and provides the latest updates on this issue. Given the latest demands made and China’s current status in the development and risk assessment of synthetic biology, we analyze the challenges that China is facing in relation to negotiation and implementation. Research in synthetic biology in China is still in its early stages. Despite the surging investments in scientific research this field, wide application and commercialization is not to be expected in the near future. China's capacity to assess risks of associated technologies is rather limited and no government agency is explicitly in charge of bio-security in this respect yet. We propose that the Chinese delegation should argue for positions including strictly controlling risks, encouraging responsible development, and calling for more technical and technological support from developed countries during the negotiations of risk assessment. Further, we suggest that establishing accountability of the governing administrative department, promoting the development of risk assessment techniques, compiling a synthetic biology national database, and organizing professional risk-assessment teams are the key implementation strategies for CBD.

Key words: synthetic biology, eco-security, new and emerging issues, implementation strategy, international negotiations, risk assessment and management

1 Benner SA, Sismour AM (2005) Synthetic biology. Nature Reviews Genetics, 6, 533-543.
2 Breitling R, Takano E (2015) Synthetic biology advances for pharmaceutical production. Current Opinion in Biotechnology, 35, 46-51.
3 CBD (Convention on Biological Diversity) (2008) Decision Adopted by the Conference of the Parties to the Convention on Biological Diversity at its Ninth Meeting IX/29. (accessed 2015-5-17)
4 CBD (Convention on Biological Diversity) (2014a) New and Emerging Issues: Synthetic Biology. (accessed 2015- 5-17)
5 CBD (Convention on Biological Diversity) (2014b) Synthetic Biology: Updated Reports. (accessed 2015-5- 17)
6 Chen GQ, Wang Y (2015) Progress in synthetic biology of “973 Funding Program” in China. Chinese Journal of Biotechnology, 31, 995-1008. (in Chinese with English abstract)
[陈国强, 王颖 (2015) 中国“合成生物学”973项目研究进展. 生物工程学报, 31, 995-1008.]
7 Collins J (2012) Synthetic Biology: Bits and pieces come to life. Nature, 483, S8-S10.
8 Endy D (2005) Foundations for engineering biology. Nature, 438, 449-453.
9 EGE (European Group on Ethics in Science and New Technologies to the European Commission) (2009) Opinion No. 25: Ethics of Synthetic Biology.
10 Garfinkel MS, Endy D, Epstein GL, Friedman RM (2007) Synthetic Genomics: Options for Governance. Biosecurity & Bioterrorism Biodefense Strategy Practice & Science, 5, 359-361.
11 Gibson DG, Glass JI, Lartigue C, Noskov VN, Noskov RY, Algire MA, Algire GA, Montague MG, Ma L, Moodie MM, Moodie C, Vashee S, Krishnakumar R, Assad-Garcia N, Assad-Garcia C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison III CA, Smith HO, Venter JC (2010) Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 329, 52-56.
12 Guan ZJ, Pei L, Schmidt M, Wei W (2012) Assessment and management of biosafety in synthetic biology. Biodiversity Science, 20, 138-150. (in Chinese with English abstract)
[关正君, 裴蕾, Markus Schmidt, 魏伟 (2012) 合成生物学生物安全风险评价与管理. 生物多样性, 20, 138-150.]
13 Kelle A (2009) Security issues related to synthetic biology between threat perceptions and governance options. In: Synthetic Biology: The Technoscience and Its Societal Consequences (eds Schmidt M, Kelle A, Ganguli A, de Vriend H), pp.101-119. Springer Academic Publishing, NewYork.
14 Kitney R, Freemont P (2012) Synthetic biology: the state of play. FEBS Letters, 15, 2029-2036.
15 Li J, Li SS, Wei Q, Wang ZJ (2013) Synthetic biology: biosafety and management strategy analysis. China Medical Equipment, 10(6), 68-71. (in Chinese with English abstract)
[李晶, 李思思, 魏强, 王子军 (2013) 合成生物学的生物安全问题及对策分析. 中国医学装备, 10(6), 68-71.]
16 Liu D, Du J, Zhao GR, Yuan YJ (2011) Applications of synthetic biology in medicine and energy. Journal of Chemical Industry and Engineering, 62, 2391-2397. (in Chinese with English abstract)
[刘夺, 杜瑾, 赵广荣, 元英进 (2011) 合成生物学在医药及能源领域的应用. 化工学报, 62, 2391-2397.]
17 Mackenzie R, Burhenne-Guilmin FLV, Antonio GM, Werksman JD (2003) An Explanatory Guide to the Cartagena Protocol on Biosafety. IUCN, Gland, Switzerland and Cambridge, UK.
18 Moe-Behrens GHG, Davis R, Haynes KA (2013) Preparing synthetic biology for the world. Frontiers in Microbiology, 4, 5.
19 PCSBI (Presidential Commission for the Study of Bioethical Issues) (2010) New Directions: The Ethics of Synthetic Biology and Emerging Technologies.
20 RAE (The Royal Academy of Engineering) (2009) Synthetic Biology: scope, applications and implications. The Royal Academy of Engineering, London.
21 SBSTTA (Subsidiary Body on Scientific, Technical and Technological Advice) (2010) New and Emerging Issues. (accessed 2015-5-17)
22 Secretariat of the Convention on Biological Diversity (2000) Cartagena Protocol on Biosafety to the Convention on Biological Diversity: Text and Annexes.
23 Sleator RD (2014) The synthetic biology future. Bioengineered, 5, 69-72.
24 Sutherland W, Clout M, Cote I, Daszak P, Depledge M, Fellman L, Fleishman E, Garthwaite R, Gibbons D, De Lurio J, Impey A, Lickorish F, Lindenmayer D, Madgwick J, Margerison C, Maynard T, Peck L, Pretty J, Prior S, Redford K, Scharlemann J, Spalding M, Watkinson A (2010) A horizon scan of global conservation issues for 2010. Trends in Ecology and Evolution, 25, 1-7.
25 The International Civil Society Working Group on Synthetic Biology (2011) A Submission to the Convention on Biological Diversity’s Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA) on the Potential Impacts of Synthetic Biology on the Conservation and Sustainable Use of Biodiversity. 013-en.pdf (accessed 2015-5-17)
26 UNICRI (United Nations Interregional Crime and Justice Research Institute) (2011) Security Implications of Synthetic Biology and Nanobiotechnology.
27 Vincent MJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnology, 7, 796-802.
28 Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM (2009) Letters: programming cells by multiplex genome engineering and accelerated evolution. Nature, 460, 894-899.
29 WTO (2006) European Communities—Measures Affecting the Approval and Marketing of Biotech Products. (accessed 2015-5-17)
30 Zhang LY, Chang SH, Wang J (2011) Synthetic biology: from the first synthetic cell to see its current situation and future development. Chinese Science Bulletin, 56, 229-237.
31 Zhu XH, Li Z (2011) The research progress and future applications of synthetic biology. Forum on Science and Technology in China, (5), 143-148. (in Chinese with English abstract)
[朱星华, 李哲 (2011), 合成生物学的研究进展与应用. 中国科技论坛, (5), 143-148.]
[1] Zhengjun Guan, Lei Pei, Markus Schmidt, Wei Wei. (2012) Assessment and management of biosafety in synthetic biology . Biodiv Sci, 20(2): 138-150.
Full text